ARCHIVES

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

This article is from The Cancer Letter archive.

Vol. 23 No. 05 | February 7, 1997

Download PDF Visit The Full Archive

Related Articles

LAK/IL-2 Therapy Could Halt Kidney Cancer Deaths: DeVita

March 21, 1986

Frank Rauscher, 62, Former NCI director, Dead Of Heart Attack

January 8, 1993

ACS Says NCI Needs $1.1 Billion, Cites Progress In Prevention, Control

April 29, 1977

Tom Curran Becomes AACR President, Hong Is President-Elect; Attendance 13,000.

April 14, 2000

Reaction: Voices Of Believers Drown Out Skeptics

November 20, 2009

“Miracle-Gro for Cancer?” ODAC Members Vent At Amgen And J&J Over Claims, Advertising.

May 18, 2007